Update on chemotherapy in the treatment of urothelial carcinoma
about
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108]Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients.Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
P2860
Update on chemotherapy in the treatment of urothelial carcinoma
description
im Oktober 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2011
@uk
name
Update on chemotherapy in the treatment of urothelial carcinoma
@en
Update on chemotherapy in the treatment of urothelial carcinoma
@nl
type
label
Update on chemotherapy in the treatment of urothelial carcinoma
@en
Update on chemotherapy in the treatment of urothelial carcinoma
@nl
prefLabel
Update on chemotherapy in the treatment of urothelial carcinoma
@en
Update on chemotherapy in the treatment of urothelial carcinoma
@nl
P2860
P921
P356
P1476
Update on chemotherapy in the treatment of urothelial carcinoma
@en
P2093
Carrie Costantini
Frederick Millard
P2860
P304
P356
10.1100/2011/590175
P407
P577
2011-10-26T00:00:00Z